{"DataElement":{"publicId":"6580615","version":"1","preferredName":"Cervical Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for cervical carcinoma, using AJCC Ed. 8 criteria.","longName":"CRVX_AJC8_ DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3431296","version":"2","preferredName":"Cervical Neoplasm Stage Grouping","preferredDefinition":"Relating to a neck, or cervix, in any sense._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2434808v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2434808","version":"1","preferredName":"Cervical Neoplasm","preferredDefinition":"Relating to a neck, or cervix, in any sense.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12844:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical","conceptCode":"C12844","definition":"Relating to a neck, or cervix, in any sense.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0643AECC-B6B2-298D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-30","modifiedBy":"ONEDATA","dateModified":"2005-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5B33563D-AAD8-5F86-E053-F662850A8021","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-10","modifiedBy":"TAYLORT","dateModified":"2019-09-03","changeDescription":"12/13/18 tmt changed workflow and reg status. 10/10/17 tt versioned for change to semantic change to Long Name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6577826","version":"1","preferredName":"Cervical Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6577826v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I","valueDescription":"Stage I Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577828","version":"1","preferredName":"Stage I Cervical Cancer AJCC v8","longName":"6577828","preferredDefinition":"Stage I includes: T1, Any N, M0. T1: Tumor confined to uterus (extension to corpus should be disregarded). M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cervical Cancer AJCC v8","conceptCode":"C139734","definition":"Stage I includes: T1, Any N, M0. T1: Tumor confined to uterus (extension to corpus should be disregarded). M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-851E-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8537-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577834","version":"1","preferredName":"Stage IVB Cervical Cancer AJCC v8","longName":"6577834","preferredDefinition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Cervical Cancer AJCC v8","conceptCode":"C139755","definition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8553-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-856C-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577836","version":"1","preferredName":"Stage IVA Cervical Cancer AJCC v8","longName":"6577836","preferredDefinition":"Stage IVA includes: T4, Any N, M0. T4: Tumor invading the mucosa of the bladder or rectum, and/or extending beyond the true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Cervical Cancer AJCC v8","conceptCode":"C139754","definition":"Stage IVA includes: T4, Any N, M0. T4: Tumor invading the mucosa of the bladder or rectum, and/or extending beyond the true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8579-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8592-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577838","version":"1","preferredName":"Stage IIIB Cervical Cancer AJCC v8","longName":"6577838","preferredDefinition":"Stage IIIB includes: T3b, Any N, M0. T3b: extending to pelvic wall and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cervical Cancer AJCC v8","conceptCode":"C139752","definition":"Stage IIIB includes: T3b, Any N, M0. T3b: extending to pelvic wall and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-859F-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-85B8-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577840","version":"1","preferredName":"Stage IIIA Cervical Cancer AJCC v8","longName":"6577840","preferredDefinition":"Stage IIIA includes: T3a, Any N, M0. T3a: Tumor involving the lower third of vagina but not extending to pelvic wall. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cervical Cancer AJCC v8","conceptCode":"C139750","definition":"Stage IIIA includes: T3a, Any N, M0. T3a: Tumor involving the lower third of vagina but not extending to pelvic wall. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-85C5-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-85DE-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577842","version":"1","preferredName":"Stage III Cervical Cancer AJCC v8","longName":"6577842","preferredDefinition":"Stage III includes: T3, Any N, M0. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cervical Cancer AJCC v8","conceptCode":"C139749","definition":"Stage III includes: T3, Any N, M0. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-85EB-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8604-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577844","version":"1","preferredName":"Stage IIB Cervical Cancer AJCC v8","longName":"6577844","preferredDefinition":"Stage IIB includes: T2b, Any N, M0. T2b: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina with parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cervical Cancer AJCC v8","conceptCode":"C139748","definition":"Stage IIB includes: T2b, Any N, M0. T2b: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina with parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8611-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-862A-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIA2","valueDescription":"Stage IIA2 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577846","version":"1","preferredName":"Stage IIA2 Cervical Cancer AJCC v8","longName":"6577846","preferredDefinition":"Stage IIA2 includes: T2a2, Any N, M0. T2a2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2 Cervical Cancer AJCC v8","conceptCode":"C139746","definition":"Stage IIA2 includes: T2a2, Any N, M0. T2a2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8637-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8650-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIA1","valueDescription":"Stage IIA1 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577848","version":"1","preferredName":"Stage IIA1 Cervical Cancer AJCC v8","longName":"6577848","preferredDefinition":"Stage IIA1 includes: T2a1, Any N, M0. T2a1: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1 Cervical Cancer AJCC v8","conceptCode":"C139745","definition":"Stage IIA1 includes: T2a1, Any N, M0. T2a1: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-865D-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8676-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577850","version":"1","preferredName":"Stage IIA Cervical Cancer AJCC v8","longName":"6577850","preferredDefinition":"Stage IIA includes: T2a, Any N, M0. T2a: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervical Cancer AJCC v8","conceptCode":"C139744","definition":"Stage IIA includes: T2a, Any N, M0. T2a: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8683-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-869C-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577852","version":"1","preferredName":"Stage II Cervical Cancer AJCC v8","longName":"6577852","preferredDefinition":"Stage II includes: T2, Any N, M0. T2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervical Cancer AJCC v8","conceptCode":"C139743","definition":"Stage II includes: T2, Any N, M0. T2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-86A9-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-86C2-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IB2","valueDescription":"Stage IB2 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577854","version":"1","preferredName":"Stage IB2 Cervical Cancer AJCC v8","longName":"6577854","preferredDefinition":"Stage IB2 includes: T1b2, Any N, M0. T1b2: Tumor with clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2 Cervical Cancer AJCC v8","conceptCode":"C139740","definition":"Stage IB2 includes: T1b2, Any N, M0. T1b2: Tumor with clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-86CF-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-86E8-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IB1","valueDescription":"Stage IB1 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577856","version":"1","preferredName":"Stage IB1 Cervical Cancer AJCC v8","longName":"6577856","preferredDefinition":"Stage IB1 includes: T1b1, Any N, M0. T1b1: Tumor with clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1 Cervical Cancer AJCC v8","conceptCode":"C139739","definition":"Stage IB1 includes: T1b1, Any N, M0. T1b1: Tumor with clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-86F5-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-870E-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577858","version":"1","preferredName":"Stage IB Cervical Cancer AJCC v8","longName":"6577858","preferredDefinition":"Stage IB includes: T1b, Any N, M0. T1b: Tumor with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. It includes all macroscopically visible lesions, even those with superficial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervical Cancer AJCC v8","conceptCode":"C139738","definition":"Stage IB includes: T1b, Any N, M0. T1b: Tumor with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. It includes all macroscopically visible lesions, even those with superficial invasion. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-871B-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8734-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IA2","valueDescription":"Stage IA2 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577860","version":"1","preferredName":"Stage IA2 Cervical Cancer AJCC v8","longName":"6577860","preferredDefinition":"Stage IA2 includes: T1a2, Any N, M0. T1a2: Invasive cervical carcinoma with measured stromal invasion of more than 3.0 mm and not more than 5.0 mm, with a horizontal spread of 7.0 mm or less. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2 Cervical Cancer AJCC v8","conceptCode":"C139737","definition":"Stage IA2 includes: T1a2, Any N, M0. T1a2: Invasive cervical carcinoma with measured stromal invasion of more than 3.0 mm and not more than 5.0 mm, with a horizontal spread of 7.0 mm or less. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8741-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-875A-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IA1","valueDescription":"Stage IA1 Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577862","version":"1","preferredName":"Stage IA1 Cervical Cancer AJCC v8","longName":"6577862","preferredDefinition":"Stage IA1 includes: T1a1, Any N, M0. T1a1: Invasive cervical carcinoma with measured stromal invasion of 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1 Cervical Cancer AJCC v8","conceptCode":"C139736","definition":"Stage IA1 includes: T1a1, Any N, M0. T1a1: Invasive cervical carcinoma with measured stromal invasion of 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-8767-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-8780-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Cervical Cancer AJCC v8","ValueMeaning":{"publicId":"6577864","version":"1","preferredName":"Stage IA Cervical Cancer AJCC v8","longName":"6577864","preferredDefinition":"Stage IA includes: T1a, Any N, M0. T1a: Tumor diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. M0: No distant metastasis. (AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cervical Cancer AJCC v8","conceptCode":"C139735","definition":"Stage IA includes: T1a, Any N, M0. T1a: Tumor diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. M0: No distant metastasis. (AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-878D-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C4BA1CE-87A6-5587-E053-F662850AB4FF","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6577825","version":"1","preferredName":"Cervical Cancer by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C139733:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Cancer by AJCC v8 Stage","conceptCode":"C139733","definition":"A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4BA1CE-84F1-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"ONEDATA","dateModified":"2018-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C4BA1CE-8502-5587-E053-F662850AB4FF","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-05","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-20-19 released per MC.; 12/5/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000442","version":"1","longName":"Cervix","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C5B6A0F-050C-4A2A-E053-F662850AD5FD","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-06","modifiedBy":"TAYLORT","dateModified":"2019-09-03","changeDescription":"9/3/19 TMT released per MC. 12/6/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}